combining glp-1 receptor agonist with dpp-4 inhibitor not recommended guideline The effect of inhibitors, agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs | Cardiovascular Diabetology Effect of combination treatment with
Description
Some of these other issues can improve so that I will be able to get off of some of these other medications because thats the whole thing
Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm2016: executive summary
Alpha-, Delta- and PP-cells: are they the architectural cornerstones of islet structure and co-ordination
Role of incretin axis in inflammatory bowel disease
doi: 10.1016/S0140-6736(16)30173-8
